Groupe de Recherche sur les Allergies ALimentaires (GRAAL)
Following complementary research training on oral immunotherapy at Stanford University in California, Dr Philippe Bégin was recruited as active researcher at the CHU Sainte-Jusine, where he established a research program in allergy healthcare delivery. In collaboration with patient groups, with the CHU Sainte-Justine Foundation and with the Ministry of Health and Social Services of the province, he initiated a pilot project for a public clinical offer in oral immunotherapy dedicated to patients suffering from severe food allergies. His research program combines clinical trials with evaluative research on the optimization and relevance of allergy clinical offer in the a public healthcare context.
Dr Bégin is cochairing the redaction first Canadian clinical practice guidelines on oral immunotherapy in collaboration with the Canadian Society of Allergy and Clinical Immunology (CSACI) and the Institut national d’excellence en santé et services sociaux (INESSS). He is also co-chair of research at the Canadian Allergy, Asthma and Immunology Foundation (CAAIF).
PubMed
Large multicentre study at Sainte-Justine University Hospital Centre urges caution
Recruitment for the trial is now complete